Next Article in Journal
Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)
Next Article in Special Issue
Neuroendocrine Tumors: Treatment and Management
Previous Article in Journal
Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer
Previous Article in Special Issue
Simultaneous Resection of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases: Safety and Oncological Efficacy
 
 
Review

Article Versions Notes

Cancers 2022, 14(5), 1119; https://doi.org/10.3390/cancers14051119
Action Date Notes Link
article pdf uploaded. 22 February 2022 17:12 CET Version of Record https://www.mdpi.com/2072-6694/14/5/1119/pdf-vor
article supplementary file uploaded. 22 February 2022 17:12 CET - https://www.mdpi.com/2072-6694/14/5/1119#supplementary
article xml file uploaded 24 February 2022 03:03 CET Original file -
article xml uploaded. 24 February 2022 03:03 CET Update https://www.mdpi.com/2072-6694/14/5/1119/xml
article pdf uploaded. 24 February 2022 03:03 CET Updated version of record https://www.mdpi.com/2072-6694/14/5/1119/pdf
article html file updated 24 February 2022 03:05 CET Original file -
article html file updated 1 August 2022 02:08 CEST Update https://www.mdpi.com/2072-6694/14/5/1119/html
Back to TopTop